Healthy Skepticism Library

Items published during the years 2000 to 2009

There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.

Page 83 of 144 pages ‹ First  < 81 82 83 84 85 >  Last ›

HSL6226
Petty RE, Brinol P.
A metacognitive approach to 'implicit' and 'explicit' evaluations: comment on Gawronski and Bodenhausen (2006).
Psychol Bull 2006 Sep 01; 132:(5):740-4

HSL6244
Shrank WH, Asch SM, Joseph GJ, Young HN, Ettner SL, Kholodenko Y, Glassman P, Kravitz RL.
Physicians' perceived knowledge of and responsibility for managing patients' out-of-pocket costs for prescription drugs.
Ann Pharmacother 2006 Sep 01; 40:(9):1534-40
http://www.theannals.com/cgi/content/full/40/9/1534

HSL6251
Stern RS.
Topical calcineurin inhibitors labeling: putting the 'box' in perspective.
Arch Dermatol 2006 Sep 01; 142:(9):1233-5
http://archderm.ama-assn.org/cgi/content/full/142/9/1233

HSL6255
Weber K, Story M, Harnack L.
Internet food marketing strategies aimed at children and adolescents: a content analysis of food and beverage brand web sites.
J Am Diet Assoc 2006 Sep 01; 106:(9):1463-6
http://linkinghub.elsevier.com/retrieve/pii/S0002-8223(06)01391-5

HSL6299
Lowe JA 3rd, Duckworth M, Jones P.
Innovation, productivity and the art of risk management.
Curr Opin Drug Discov Devel 2006 Sep 01; 9:(5):549-50

HSL6300
Marris E.
Pfizer hires 'outsider' for insider top job.
Nat Rev Drug Discov 2006 Sep 01; 5:(9):709

HSL6303
Krall RL, Rockhold F.
Reasons for optimism not disillusionment.
J R Soc Med 2006 Sep 01; 99:(9):435
http://www.jrsm.org/cgi/content/full/99/9/435

HSL6305
Fehr A, Thurmann P, Razum O.
Editorial: drug development for neglected diseases: a public health challenge.
Trop Med Int Health 2006 Sep 01; 11:(9):1335-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-3156.2006.01714.x

HSL6306
Liyanage SS, Raina Macintyre C.
Do financial factors such as author page charges and industry funding impact on the nature of published research in infectious diseases?
Health Info Libr J 2006 Sep 01; 23:(3):214-22
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1471-1842.2006.00665.x

HSL6364
Paterson JM, Laupacis A, Bassett K, Anderson GM;.
Using pharmacoepidemiology to inform drug coverage policy: initial lessons from a two-province collaborative
Health Aff (Millwood). 2006 Sep 1; 25:(5):1436-43

HSL6385
Diagnostic tests for HIV resistance are created as quickly as the new drugs. Research is leading individualized medicine evolution.
AIDS Alert 2006 Sep 01; 21:(9):97-9

HSL6386
Kahn J.
Race, pharmacogenomics, and marketing: putting BiDil in context.
Am J Bioeth 2006 Sep-Oct 01; 6:(5):W1-5
http://taylorandfrancis.metapress.com/(oixjarzvu5bbwwilaz5wcvij)/app/home/contribution.asp?referrer=parent&backto=issue,28,33;journal,1,27;linkingpublicationresults,1:111605,1

HSL6387
Kearney G.
Strategic questioning the way to shift opinion.
Aust Nurs J 2006 Sep 01; 14:(3):44

HSL6389
Bosmans JM, Spinhoven MJ, Deckers FP, Pouillon MM, Borre FJ, Parizel PM.
Accidental ingestion of a press-through package: an underestimated cause of serious iatrogenic disease in the elderly?
J Am Geriatr Soc 2006 Sep 01; 54:(9):1467-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1532-5415.2006.00858.x

HSL7559
Young D.
Safety nets still overpaying for drugs.
Am J Health Syst Pharm 2006 Sep 1; 63:(17):1584,
http://www.ajhp.org/cgi/content/full/63/17/1584

HSL8144
Burkette S.
Alternative Media: The Download on Podcasting
Pharmaceutical Executive 2006 Sep 1
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=369281&pageID=1

HSL19787
Eccies K
Divisions' bid to take over pharma education a hard sell
Medical Observer 2006 Sep 1

HSL20055
Anastasopoulos C
ADGP spruiks for 'party plan' role
Australian Doctor 2006 Sep 16

HSL6220
Ahmad K.
Abbott accused of refusing access to HIV drug.
Lancet Infect Dis 2006 Sep; 6:(9):547

HSL6221
Twery MJ.
The cartoon character garfield and the 'sleep well. Do well. Star sleeper' campaign.
Pediatrics 2006 Sep; 118:(3):1259

HSL7507
Stolk P, Willemen MJ, Leufkens HG.
Rare essentials: drugs for rare diseases as essential medicines.
Bull World Health Organ 2006 Sep; 84:(9):745-51

HSL7508
Reidenberg MM.
Are drugs for rare diseases "essential"?
Bull World Health Organ 2006 Sep; 84:(9):686

HSL7516
Reidak A.
Were Eli Lilly unaware of this study?
PLoS Med 2006 Sep; 3:(9):e408
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030408

HSL7518
Tormala ZL, Clarkson JJ, Petty RE.
Resisting persuasion by the skin of one's teeth: the hidden success of resisted persuasive messages.
J Pers Soc Psychol 2006 Sep; 91:(3):423-35
http://content.apa.org/journals/psp/91/3/423

HSL7522
Pawlotsky JM.
Science, medicine and the markets.
J Hepatol 2006 Sep; 45:(3):341-2
http://linkinghub.elsevier.com/retrieve/pii/S0168-8278(06)00340-0

HSL7542
Goni S.
[Divided responsibilities: Role of industry.]
Encephale 2006 Sep; 32:
http://www.masson.fr/masson/portal/bookmark?Global=1&Page=18&MenuIdSelected=106&MenuItemSelected=0&MenuSupportSelected=0&CodeProduct4=539&CodeRevue4=ENC&Path=REVUE/ENC/2006/32/4C3/ARTICLE11574617826.xml&Locations=

HSL7546
Dossey L.
Listerine's long shadow: disease mongering and the selling of sickness.
Explore (NY) 2006 Sep-Oct; 2:(5):379-85
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16979097&dopt=Abstract

HSL7551
Wang M, Chen Y.
Age differences in attitude change: influences of cognitive resources and motivation on responses to argument quantity.
Psychol Aging 2006 Sep; 21:(3):581-9
http://content.apa.org/journals/pag/21/3/581

HSL7553
O'Connell D, Roblin D.
Translational research in the pharmaceutical industry: from bench to bedside.
Drug Discov Today 2006 Sep; 11:(17-18):833-8
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T64-4KRFS3R-B&_coverDate=09%2F30%2F2006&_alid=528326543&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5020&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=571ec392e21d22a997f70573612ddae6

HSL7556
Schmid EF, Smith DA.
R&D technology investments: misguided and expensive or a better way to discover medicines.
Drug Discov Today? 2006 Sep; 11:(17-18):775-84
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16935744&dopt=Abstract

HSL7560
de Pouvourville G.
Risk-sharing agreements for innovative drugs: a new solution to old problems?
Eur J Health Econ 2006 Sep; 7:(3):155-7
http://www.springerlink.com/content/9v40j71827xl2635/

HSL7561
Lott JP, Katz KA.
Pharmaceutical companies' policies and practices regarding prospective registration of dermatology-related clinical trials.
Br J Dermatol. 2006 Sep; 155:(3):635-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2133.2006.07386.x

HSL7565
Dalen DM, Strom S, Haabeth T.
Price regulation and generic competition in the pharmaceutical market.
Eur J Health Econ 2006 Sep; 7:(3):208-14
http://www.springerlink.com/content/t385365538697l50/

HSL7582
Schrank B, Seyringer ME, Berger P, Katschnig H, Amering M.
[Schizophrenia and psychosis on the internet ]
Psychiatr Prax. 2006 Sep; 33:(6):277-81
http://www.thieme-connect.com/DOI/DOI?10.1055/s-2005-915320

HSL7591
de Lorgeril M, Salen P.
Cholesterol lowering and mortality: time for a new paradigm?
Nutr Metab Cardiovasc Dis 2006 Sep; 16:(6):387-90
http://linkinghub.elsevier.com/retrieve/pii/S0939-4753(06)00124-4

HSL7671
Brewer GJ.
Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required.
J Investig Med 2006 Sep; 54:(6):291-302
http://www.bcdecker.com/pubMedLinkOut.aspx?pub=JIMO&vol=54&iss=6&page=291

HSL7690
Hall W.
Ensuring that addiction science is deserving of public trust.
Addiction 2006 Sep; 101:(9):1223-4
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1360-0443.2006.01552.x

HSL8019
Dormont B, Grignon M, Huber H.
Health expenditure growth: reassessing the threat of ageing.
Health Econ 2006 Sep; 15:(9):947-63
http://www3.interscience.wiley.com/cgi-bin/abstract/112776605/ABSTRACT?CRETRY=1&SRETRY=0

HSL8049
Mathez P, Chapuis S.
[Blood transfusion and advertising].
Transfus Clin Biol. 2006 Sep; 13:(3):211-4
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VN7-4KVXHWM-1&_user=10&_coverDate=09%2F30%2F2006&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0393582c6798cca1a65f4bbb56743ad9

HSL8050
Mathez P, Chapuis S.
[Blood transfusion and advertising].
Transfus Clin Biol. 2006 Sep; 13:(3):211-4
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VN7-4KVXHWM-1&_user=10&_coverDate=09%2F30%2F2006&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0393582c6798cca1a65f4bbb56743ad9

HSL8051
Mathez P, Chapuis S.
[Blood transfusion and advertising].
Transfus Clin Biol 2006 Sep; 13:(3):211-4
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VN7-4KVXHWM-1&_user=10&_coverDate=09%2F30%2F2006&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0393582c6798cca1a65f4bbb56743ad9

HSL8212
Courcier S, Sibenaler C, Couderc M, Trinquet F, Pletan Y, Lassale C; Groupe de travail attractivite de la France du Leem.
[The attractive position of France in international clinical research: 2006 survey assessed by Leem (French pharmaceutical companies)].
Therapie 2006 Sep-Oct; 61:(5):407-18
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17243270&query_hl=10&itool=pubmed_DocSum

HSL8315
Myhr G, Payne K.
Cost-effectiveness of cognitive-behavioural therapy for mental disorders: implications for public health care funding policy in Canada.
Can J Psychiatry 2006 Sep; 51:(10):662-70
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17052034&query_hl=2&itool=pubmed_DocSum

HSL8683
Fisher JA.
Co-ordinating 'ethical' clinical trials: the role of research coordinators in the contract research industry.
Sociol Health Illn 2006 Sep; 28:(6):678-94
http://www.blackwell-synergy.com/doi/full/10.1111/j.1467-9566.2006.00536.x

HSL8733
Mani MK.
Advertising again.
Natl Med J India 2006 Sep-Oct; 19:(5):287-8
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17203687&query_hl=16&itool=pubmed_DocSum

HSL8734
George T, Srinivasan S.
Does the TGN1412 trial disaster have lessons for clinical trials in India?
Natl Med J India 2006 Sep-Oct; 19:(5):283-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17203685&query_hl=18&itool=pubmed_DocSum

HSL8748
Booth RE Jr.
Truth in advertising: the ethical limits of direct-to-consumer marketing.
Orthopedics 2006 Sep; 29:(9):780-1
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17004586&query_hl=2&itool=pubmed_DocSum

HSL9002
Meadows M, Weitzman M.
Advancing public health through partnerships.
FDA Consum 2006 Sep-Oct; 40:(5):27-36
http://www.fda.gov/fdac/features/2006/506_partnerships.html

HSL9024
Hilbrich L, Sleight P.
Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials.
Eur Heart J 2006 Sep; 27:(18):2158-64
http://eurheartj.oxfordjournals.org/cgi/content/full/27/18/2158

HSL9109
Gebhardt DO.
The generic-patent medicine conflict flares up again in The Netherlands.
J Med Ethics 2006 Sep; 32:(9):555
http://jme.bmj.com/cgi/content/full/32/9/555

HSL12178
De Vries R, Elliott C.
Why disclosure?
J Gen Intern Med 2006 Sep; 21:(9):1003-4
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16918750

HSL12247
Tomaszewski C.
Off-label: just what the doctor ordered.
J Med Toxicol 2006 Sep; 2:(3):87-8
http://www.ncbi.nlm.nih.gov/pubmed/18072123

HSL6017
Cassels A.
Big Pharma holds drug and advocacy groups hostage
Common Ground 2006 Aug 31
http://www.commonground.ca/iss/0609182/cg182_Cassels.shtml

HSL6019
Pringle E.
Big Pharma Bankrupting US Health Care System
OpEdNews.com 2006 Aug 31
http://www.opednews.com/articles/genera_evelyn_p_060831_big_pharma_bankrupti.htm

HSL6021
Reischel J.
In Cord Blood : Turning the miracle of birth into the banking of cold, hard cash.
New Times B-PB 2006 Aug 31
http://www.newtimesbpb.com/Issues/2006-08-31/news/feature_full.html

HSL6020
Pringle E.
Spotlight Focused On Pfizer's Lipitor Follies
Scoop Independent News 2006 Aug 30
http://www.scoop.co.nz/stories/HL0608/S00363.htm

HSL6023
Wasowicz L.
Ped Med: Anti-depressant questions rise
UPI ( United Press International) 2006 Aug 30
http://www.upi.com/ConsumerHealthDaily/view.php?StoryID=20060825-012004-3650r

HSL6068
Whitney J.
How drug reps know which doctors to target. : Big (Brother) Pharma
New Republic online 2006 Aug 29
https://ssl.tnr.com/p/docsub.mhtml?i=w060828&s=whitney082906

HSL6253
Vere-Jones E.
Private sector nurse training set to grow.
Nurs Times 2006 Aug 29-Sep;

HSL6024
FDA Advisory Committee: Does Approval Mean Safety?
National Research Center for Women & Families 2006 Aug 28
http://www.center4research.org/news/fda-app-safety.html

HSL5956
The Paquin Group is the nation's leading healthcare retail consultancy.
Paquin Group 2006 Aug 27
http://www.thepaquingroup.com/

HSL6025
Douglas D.
Antidepressants during pregnancy may affect baby
Reuters 2006 Aug 26
http://today.reuters.co.uk/news/articlenews.aspx?type=healthNews&storyID=2006-08-26T000122Z_01_PAR600007_RTRIDST_0_HEALTH-ANTIDEPRESSANTS-DC.XML

HSL5952
Armstrong D.
Medical Journal Editor to Quit In Wake of Disclosure Oversight
Wall St Journal 2006 Aug 25
http://online.wsj.com/public/us

HSL19838
Ferguson H
Drug lobby scoffs at muffin rule
Australian Doctor 2006 Aug 25

HSL19916
Lewindon N
Free time is worth a free lunch
Australian Doctor 2006 Aug 2523

HSL20202
Jenkins R
Weight-loss drug wins ad battle
Australian Doctor 2006 Aug 2511
http://www.australiandoctor.com.au/news/latest-news/weight-loss-drug-wins-ad-battle

HSL5955
Berenson A.
Merck Sees Successor to Vioxx
New York Times 2006 Aug 24
http://www.nytimes.com/glogin?URI=http://www.nytimes.com/2006/08/24/business/24merck.html&OQ=_rQ3D2Q26thQ3DQ26orefQ3DsloginQ26emcQ3DthQ26pagewantedQ3Dprint&OP=3d4b0063Q2FQ27!oQ24Q27A_2cQ7C__Q25GQ27GJJuQ27J1Q27GQ22Q27Q24Q3FcQ5E.occQ27GQ227oQ7C26Q3CVQ257j

HSL6097
Bishop G, Brodkey A.
Personal Responsibility and Physician Responsibility — West Virginia's Medicaid Plan
New England Journal of Medicine (NEJM) 2006 Aug 24355:(8):756
http://content.nejm.org/cgi/content/full/355/8/756

HSL5921
Whalen J.
Armed With New Vaccines, Drug Makers Target Teenagers
The Wall Street Journal 2006 Aug 23
http://online.wsj.com/article_email/SB115629605880042909-lMyQjAxMDE2NTI2MzIyOTM2Wj.html

HSL5953
Wasowicz L.
Ped Med: Can Rx's cut suicide risk?
UPI ( United Press International) 2006 Aug 23
http://www.upi.com/ConsumerHealthDaily/view.php?StoryID=20060823-025001-6077r

HSL5959
Schmit J.
More drugs get slapped with lawsuits : Drug makers faced the most product liability lawsuits last year of any
USA Today 2006 Aug 23
http://www.usatoday.com/money/industries/health/drugs/2006-08-23-drug-lawsuits-usat_x.htm?POE=click-refer

HSL6018
Fugh-berman A.
The Dog Ate My Disclosure
Bioethics Forum 2006 Aug 23
http://www.bioethicsforum.org/20060823afughberman.asp

HSL5583
Groves T.
Whose research is it anyway?
BMJ 2006 Aug 22; 333:(7560):
http://bmj.bmjjournals.com/cgi/content/short/333/7560/0-f?etoc%3e

HSL5918
Metherell M.
One in four hip, knee replacements needs redoing
Sydney Morning Herald 2006 Aug 22
http://www.smh.com.au/news/national/one-in-four-hip-knee-replacements-needs-redoing/2006/08/21/1156012474008.html

HSL5920
Harris G.
F.D.A. Strengthens Warnings on Stimulants' Risks
New York Times 2006 Aug 22
http://www.nytimes.com/2006/08/22/health/policy/22fda.html?_r=1&hp&ex=1156219200&en=50705e06df3eb2a7&ei=5094&partner=homepage&oref=slogin

HSL5922
Bernstein E.
A New Breed Of 'Diet' Pills Drugs Approved for Diabetes, Depression, Epilepsy Grow Popular For Their Weight-Loss Side Effects
Wall St Journal 2006 Aug 22
http://online.wsj.com/article_email/SB115620617571041689-lMyQjAxMDE2NTI2MzIyMDM2Wj.html

HSL5957
Veneracion C.
Ban milk formula ads
Manila Standard 2006 Aug 22

HSL5960
US FDA cancels advisory committee meeting to review Wyeth's desvenlafaxine data
Forbes 2006 Aug 22
http://www.forbes.com/markets/feeds/afx/2006/08/22/afx2965995.html

HSL6110
Schopick J.
The JAMA Controversy
Honest Medicine: My Dream for the Future 2006 Aug 22
http://honestmedicine.typepad.com/medical_watch/2006/07/the_jama_contro_1.html

HSL10832
Pinheiro E, Vasan A, Kim JY, Lee E, Guimier JM, Perriens J.
Examining the production costs of antiretroviral drugs.
AIDS 2006 Aug 22; 20:(13):1745-52
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00002030-200608220-00008

HSL5917
Pringle E.
OpEd News
Lawmakers Sever Ties Between CDC And Big Pharma 2006 Aug 21
http://www.opednews.com/articles/genera_evelyn_p_060821_lawmakers_sever_ties.htm

HSL5923
Arnst C.
Taking A Shine To Your Rx
Business Week 2006 Aug 21
http://www.businessweek.com/magazine/content/06_34/c3998003.htm#ZZZBTBQUOQE

HSL5954
Rowe J.
Drug ads sell a problem, not a solution
Christian Science Monitor 2006 Aug 21
http://news.yahoo.com/s/csm/yrowe&printer=1

HSL5913
Metherell M.
Days of GP perks are over, says lobbyist
Sydney Morning Herald 2006 Aug 19
http://www.smh.com.au/news/national/days-of-gp-perks-are-over-says-lobbyist/2006/08/18/1155408025308.html

HSL5916
Priest A.
A look inside a doctor's mailbox
Shared Vision 2006 Aug 19
http://www.shared-vision.com/2006/sv1908/PostTraumatic.html

HSL5945
Tite L, Schroter S.
Evidence based publishing.
BMJ 2006 Aug 19; 333:(7564):366
http://bmj.bmjjournals.com/cgi/content/short/333/7564/366?etoc%3e

HSL5946
Dyer O.
GSK breached marketing code.
BMJ 2006 Aug 19; 333:(7564):368
http://bmj.bmjjournals.com/cgi/content/short/333/7564/368-a?etoc%3e

HSL5947
Tanne J.
JAMA's editor stresses authors' need to disclose financial ties.
BMJ 2006 Aug 19; 333:(7564):370
http://bmj.bmjjournals.com/cgi/content/short/333/7564/370-c?etoc%3e

HSL6075
Memory enhancement--a neuroethical dilemma.
Lancet 2006 Aug 19; 368:(9536):620
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(06)69219-2

HSL5885
Berenson A.
Merck Suffers a Pair of Setbacks Over Vioxx
New York Times 2006 Aug 18
http://www.nytimes.com/2006/08/18/business/18merck.html?ex=1156564800&en=8cbda95e32095183&ei=5070&emc=eta1

HSL5887
Franklin M.
Medicos' reversal on free lunches
The Australian Newswpaper 2006 Aug 18
http://www.theaustralian.news.com.au/story/0,20867,20167710-23289,00.html

HSL5912
Pringle E.
Lawmakers Say FDA Better Clean Up Its Act
Lawyers and Settlements 2006 Aug 18
http://www.lawyersandsettlements.com/articles/FDA_Pharma.html

HSL19827
Carter H
Bayer forced to pull Levitra offer
Australian Doctor 2006 Aug 18
http://www.australiandoctor.com.au/news/bayer-forced-to-pull-levitra-offer

HSL20057
Smith P
Taking gifts is criminal
Australian Doctor 2006 Aug 187
http://www.australiandoctor.com.au/news/latest-news/taking-gifts-is-criminal

HSL20058
Smith P
Let's not kid ourselves: we can be influenced
Medical Observer 2006 Aug 1827

HSL20059
Hart D
Stand up for doctors' integrity
Australian Doctor 2006 Aug 1827

HSL5888
Abbott supports freebies for doctors to be regulated
Sydney Morning Herald 2006 Aug 17
http://www.smh.com.au/news/national/freebies-for-doctors-to-be-regulated/2006/08/17/1155407949242.html

HSL5892
Foster M.
Jury Rules Against Merck on Vioxx
Associated Press 2006 Aug 17
http://www.washingtonpost.com/wp-dyn/content/article/2006/08/17/AR2006081700557_pf.html

HSL5894
Franklin M.
Pharma defies watchdog
The Australian Newswpaper 2006 Aug 17
http://www.theaustralian.news.com.au/story/0,20867,20155548-2702,00.html

HSL5895
Steinman M.
I am pleased to announced the existence of the Drug Industry Document Archive, a new online archive of documents that describes drug industry marketing.
Drug Industry Document Archive 2006 Aug 17
http://dida.library.ucsf.edu

Page 83 of 144 pages ‹ First  < 81 82 83 84 85 >  Last ›